The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

NORFENFLURAMINE     1-[3-(trifluoromethyl) phenyl]propan-2-amine

Synonyms: SureCN44927, AGN-PC-00JZGH, AG-C-50050, NSC-43036, JP 92, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of NORFENFLURAMINE

  • We propose that preferential stimulation of valvular 5-HT(2B) receptors by norfenfluramine, ergot drugs, or 5-HT released from carcinoid tumors (with or without accompanying 5-HT(2A) receptor activation) may contribute to valvular fibroplasia in humans [1].
  • In contrast to two previous reports, however, there was no correlation between plasma levels of fenfluramine and its metabolite norfenfluramine and weight loss, nor was there any correlation between these levels and side effects [2].
  • N-(2-Benzoyloxyethyl) norfenfluramine (S-780) was administered to rats by stomach tube at a dose of 50 mg kg-1 of body weight [3].
 

Psychiatry related information on NORFENFLURAMINE

 

High impact information on NORFENFLURAMINE

 

Biological context of NORFENFLURAMINE

 

Anatomical context of NORFENFLURAMINE

 

Associations of NORFENFLURAMINE with other chemical compounds

 

Gene context of NORFENFLURAMINE

 

Analytical, diagnostic and therapeutic context of NORFENFLURAMINE

References

  1. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Fitzgerald, L.W., Burn, T.C., Brown, B.S., Patterson, J.P., Corjay, M.H., Valentine, P.A., Sun, J.H., Link, J.R., Abbaszade, I., Hollis, J.M., Largent, B.L., Hartig, P.R., Hollis, G.F., Meunier, P.C., Robichaud, A.J., Robertson, D.W. Mol. Pharmacol. (2000) [Pubmed]
  2. Plasma fenfluramine levels, weight loss and side effects: a failure to find a relationship. Pietrusko, R., Stunkard, A., Brownell, K., Campbell, D.B. International journal of obesity. (1982) [Pubmed]
  3. The effects of administering N-(2-benzoyloxyethyl) norfenfluramine to rats on the hepatic synthesis of glycerolipids. Brindley, D.N., Bowley, M., Burditt, S., Pritchard, H., Lloyd-Davies, K.A., Boucrot, P. J. Pharm. Pharmacol. (1976) [Pubmed]
  4. Hypothalamic serotonin in the control of meal patterns and macronutrient selection. Shor-Posner, G., Grinker, J.A., Marinescu, C., Brown, O., Leibowitz, S.F. Brain Res. Bull. (1986) [Pubmed]
  5. Pharmacological evaluation of 2-amino-6(7)- and 9-amino-6-trifluoromethylbenzonorbornenes, the conformationally rigid analogues of norfenfluramine in mice. Gray, N.M., Lu, M.C., Bhargava, H.N. Gen. Pharmacol. (1993) [Pubmed]
  6. Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor. Setola, V., Dukat, M., Glennon, R.A., Roth, B.L. Mol. Pharmacol. (2005) [Pubmed]
  7. Binding orientation of amphetamine and norfenfluramine analogues in the benzonorbornene and benzobicyclo[3.2.1]octane ring systems at the active site of phenylethanolamine N-methyltransferase (PNMT). Grunewald, G.L., Markovich, K.M., Sall, D.J. J. Med. Chem. (1987) [Pubmed]
  8. Factors controlling the activities of phosphatidate phosphohydrolase and phosphatidate cytidylyltransferase. The effects of chlorpromazine, demethylimipramine, cinchocaine, norfenfluramine, mepyramine and magnesium ions. Sturton, R.G., Brindley, D.N. Biochem. J. (1977) [Pubmed]
  9. The effects of intracerebral norfenfluramine on body temperature of the rat. Kruk, Z.L. J. Pharm. Pharmacol. (1976) [Pubmed]
  10. Comparative biodisposition and metabolism of 14C-(+/-)-fenfluramine in mouse, rat, dog and man. Marchant, N.C., Breen, M.A., Wallace, D., Bass, S., Taylor, A.R., Ings, R.M., Campbell, D.B., Williams, J. Xenobiotica (1992) [Pubmed]
  11. The effect of fenfluramine dosage regimen and reduced food intake on levels of 5-HT in rat brain. Rose, S., Hindmarsh, J.G., Collins, P., Jenner, P. Journal of neural transmission (Vienna, Austria : 1996) (1997) [Pubmed]
  12. Fenfluramine and norfenfluramine on glucose uptake into skeletal muscle. Kirby, M.J., Turner, P. Postgraduate medical journal. (1975) [Pubmed]
  13. 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Setola, V., Hufeisen, S.J., Grande-Allen, K.J., Vesely, I., Glennon, R.A., Blough, B., Rothman, R.B., Roth, B.L. Mol. Pharmacol. (2003) [Pubmed]
  14. Influence of fenfluramine and norfenfluramine stereoisomers on the firing rate of central monoaminergic neurons in the rat. Scuvée-Moreau, J., Dresse, A. Eur. J. Pharmacol. (1990) [Pubmed]
  15. Response of extrapyramidal and limbic neuropeptides to fenfluramine administration: comparison with methamphetamine. Hanson, G.R., Singh, N., Bush, L., Gibb, J.W. J. Pharmacol. Exp. Ther. (1991) [Pubmed]
  16. Serotonin, impulsivity, and alcohol use disorders in the older adolescent: a psychobiological study. Soloff, P.H., Lynch, K.G., Moss, H.B. Alcohol. Clin. Exp. Res. (2000) [Pubmed]
  17. Effect of norfenfluramine and two structural analogues on brain 5-hydroxyindoles and serum prolactin in rats. Fuller, R.W., Snoddy, H.D., Clemens, J.A., Molloy, B.B. J. Pharm. Pharmacol. (1982) [Pubmed]
  18. Interactions of iprindole with fenfluramine metabolism in rat brain and liver. Hegadoren, K.M., Baker, G.B., Coutts, R.T., Dewhurst, W.G. Journal of psychiatry & neuroscience : JPN. (1991) [Pubmed]
 
WikiGenes - Universities